Background: Nervous and muscular adverse events (NMAEs) have garnered considerable
attention after the vaccination against coronavirus disease (COVID-19). However, the …

COVID-19 vaccines have proven to be very safe in the clinical trials, however, there is less
evidence comparing the safety of these vaccines in real-world settings. Therefore, we aim to …

Health-care professionals in Ghana were among the prioritized high-risk groups to be
administered with the initial supply of Oxford/AstraZeneca vaccine procured by the …

Although neurological complications after the administration of vaccines against coronavirus
disease 2019 (COVID-19) are rare, they might result in long-term morbidity. This study was …

Background: The production of a successful vaccine has become a global dream since the
declaration of coronavirus disease 2019 (COVID-19) as a global pandemic by the World …

Abstract The coronavirus disease 2019 (COVID‐19) pandemic has affected millions of
individuals worldwide. The global scientific effort to design an effective vaccine against this …

Since the declaration of Coronavirus-2019 (COVID-19) as a pandemic by the World Health
Organization (WHO), it was clear that vaccination is the best way to overcome it. Sinopharm …

Importance Uptake of vaccination against COVID-19 is strongly affected by concerns about
adverse effects. Research on nocebo effects suggests that these concerns can amplify …

In mRNA COVID-19 vaccination, side effects after the first and second dose have been well
reported. However, studies about side effects after booster vaccine are sparse. 272 …

Background High speed of COVID-19 vaccination has raised some concerns about the
safety of the new vaccines. It is of a great importance to perform a review of the safety and …